New Rules for Clinical Trials Conducted in the EU

The European Parliament voted for new rules for clinical trials conducted in the EU. They aim at restoring the EU’s competitiveness in clinical research and the development of new and innovative treatments and medicines. Among the main rules are: creating a straightforward authorisation procedure allowing for a fast and thorough assessment of the application, simplified reporting procedures for researchers, the possibility for the Commission to conduct controls in EU countries and third countries to make sure the rules are being properly supervised and enforced. The new Regulation is expected to come into effect in mid-2016. For more information, please visit the official website of the EC.